EZ SPERSE Trademark

Trademark Overview


On Wednesday, February 24, 2016, a trademark application was filed for EZ SPERSE with the United States Patent and Trademark Office. The USPTO has given the EZ SPERSE trademark a serial number of 79187004. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, June 9, 2023. This trademark is owned by Dexcel Pharma Technologies Ltd.. The EZ SPERSE trademark is filed in the Pharmaceutical Products category with the following description:

Orally disintegrating tablets and orally disintegrating medicaments for the treatment of genetic, cardiovascular, central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, dermatological, infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, erectile dysfunction, sexual dysfunction, gynecology, obstetric, pediatric, hematologic, oncological, fungal and viral diseases and disorders
ez sperse

General Information


Serial Number79187004
Word MarkEZ SPERSE
Filing DateWednesday, February 24, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, June 9, 2023
Registration Number5084459
Registration DateTuesday, November 22, 2016
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 6, 2016

Trademark Statements


Description of MarkThe mark consists of the wording "EZ" above "SPERSE" all shown in blue, above and to the right of which are eight circles shown in blue and gray. The white in the mark is background only and is not claimed as a feature of the mark.
Goods and ServicesOrally disintegrating tablets and orally disintegrating medicaments for the treatment of genetic, cardiovascular, central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, dermatological, infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, erectile dysfunction, sexual dysfunction, gynecology, obstetric, pediatric, hematologic, oncological, fungal and viral diseases and disorders
Pseudo MarkEASY SPHERES
Indication of Colors claimedThe color(s) blue and gray is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 9, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDexcel Pharma Technologies Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIL

Party NameDexcel Pharma Technologies Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIL

Party NameDexcel Pharma Technologies Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIL

Trademark Events


Event DateEvent Description
Sunday, March 17, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Monday, February 26, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, February 26, 2024INVALIDATION PROCESSED
Friday, February 9, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, June 9, 2023CANCELLED SECTION 71
Monday, November 22, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, April 17, 2018LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, March 23, 2018LIMITATION OF GOODS RECEIVED FROM IB
Saturday, April 1, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, March 9, 2017FINAL DISPOSITION NOTICE SENT TO IB
Thursday, March 9, 2017FINAL DISPOSITION PROCESSED
Wednesday, February 22, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 22, 2016REGISTERED-PRINCIPAL REGISTER
Sunday, October 2, 2016NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, September 6, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 6, 2016PUBLISHED FOR OPPOSITION
Wednesday, August 17, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 17, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 17, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 3, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 2, 2016ASSIGNED TO LIE
Friday, July 22, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 20, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 20, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 20, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, July 9, 2016REFUSAL PROCESSED BY IB
Friday, June 17, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, June 17, 2016REFUSAL PROCESSED BY MPU
Friday, June 17, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, June 16, 2016NON-FINAL ACTION WRITTEN
Thursday, June 9, 2016ASSIGNED TO EXAMINER
Tuesday, May 31, 2016APPLICATION FILING RECEIPT MAILED
Friday, May 27, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 26, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB